Toxic-Free Beauty Act of 2025
- Sponsor
- Rep. Schakowsky, Janice D. [D-IL-9]
- Committees
- Energy and Commerce Committee (primary)
- Last action
- Jul 16, 2025
Bottom line
The Toxic-Free Beauty Act of 2025 aims to enhance cosmetic safety by banning numerous chemical ingredients and limiting contaminants, while preserving states' rights to impose even stricter regulations.
What it actually does
This bill amends the Federal Food, Drug, and Cosmetic Act to ban specific intentionally added chemicals, such as certain ortho-phthalates, formaldehyde-releasing preservatives, mercury, and various parabens, from cosmetic products. It also sets strict limits on the presence of certain contaminants like 1,4 dioxane, lead, and asbestos in cosmetics. Furthermore, the bill explicitly prevents federal law from preempting states from enacting their own stricter bans or limits on cosmetic ingredients and contaminants.
Proponents argue
Proponents argue that this bill is a crucial step to protect public health by removing harmful chemicals from everyday cosmetic products, many of which have been linked to serious health issues. They contend that current federal regulations are outdated and insufficient, lagging behind scientific understanding and international standards, and that consumers deserve safer products without having to navigate a complex landscape of potentially toxic ingredients. The non-preemption clause is seen as vital for allowing states to innovate and respond to emerging scientific concerns more quickly.
Opponents contend
Opponents, primarily from the cosmetics industry, may argue that the proposed bans are overly broad, not always scientifically justified for the trace amounts found, and could lead to significant reformulation costs and supply chain disruptions. They might also contend that a patchwork of state-specific regulations, enabled by the non-preemption clause, would create an unmanageable regulatory burden, stifle innovation, and ultimately increase costs for consumers without a clear safety benefit. Some may also argue that existing federal oversight is adequate or that a more harmonized federal approach is preferable to state-by-state variations.
The bill is short and relatively straightforward, making it accessible for a quick read and evaluation by an informed citizen.
Section 2(a), amending Section 601(h) of the FD&C Act
Ban on Intentionally Added Ortho-Phthalates and Formaldehyde-Releasing Preservatives
This provision makes a cosmetic product adulterated (and thus illegal to introduce into interstate commerce) if it contains any intentionally added ortho-phthalate or formaldehyde-releasing preservative. This is a broad ban targeting entire classes of chemicals commonly used in cosmetics for various purposes, such as fragrance carriers or antimicrobial agents.
Supporters argue
Supporters argue that ortho-phthalates and formaldehyde-releasing preservatives are linked to adverse health effects, including endocrine disruption and allergic reactions, and their removal is essential for consumer safety. They contend that safer alternatives exist and should be prioritized.
Critics contend
Industry groups may argue that many of these substances are safe at current usage levels and that a blanket ban is an overreach that could eliminate effective and affordable ingredients, forcing manufacturers to use less tested or more expensive alternatives.
Tradeoffs
The provision balances consumer health protection against potential reformulation costs for industry and possible impacts on product performance or availability. It also reflects a tension between precautionary principle and risk-based regulation.
Section 2(a), amending Section 601(i) of the FD&C Act
Ban on Specific Intentionally Added Ingredients
This section prohibits a list of 15 specific intentionally added ingredients from being present in cosmetic products. The list includes substances like formaldehyde, mercury and mercury compounds, isobutylparaben, isopropylparaben, Lilial, styrene, toluene, triclosan, triclocarban, and cyclotetrasiloxane, among others. Each substance is identified by its common name and CAS number.
Section 2(a), amending Section 601(j) of the FD&C Act
Limits on Contaminants in Cosmetic Products
This provision establishes maximum allowable levels for certain contaminants in cosmetic products. Specifically, 1,4 dioxane is limited to 2 parts per million (ppm), lead and lead compounds to 2 ppm for color cosmetics and 5 ppm for general cosmetics, and asbestos or asbestos-containing compounds (including asbestos-contaminated talc) are banned at the lowest possible limit of detection.
Section 2(c), amending Section 614(b) of the FD&C Act
Non-Preemption of State Laws
This amendment clarifies that federal law does not prevent states or their political subdivisions from prohibiting or limiting the use or amount of any ingredient in a cosmetic product. Specifically, it allows states to implement requirements that prohibit or limit the ingredients and contaminants banned or restricted by this Act, or to continue existing state requirements that were in effect prior to the enactment of the 'Toxic-Free Beauty Act of 2025' or the 'Modernization of Cosmetics Regulation Act of 2022'.
This section defines key terms, including 'contaminant' as a chemical not intentionally added, incidental to manufacturing, and serving no intended function. It also distinguishes 'color cosmetic' from 'general cosmetic' for the purpose of lead limits, and defines 'intentionally added' as a chemical serving an intended function.
Section 2(b), amending Section 604 of the FD&C Act
Why it matters:Placing definitions in a dedicated section is standard legislative practice to ensure clarity and avoid repetition within the operative text. It is not necessarily evasive.
Case for: Defining terms precisely ensures that the regulatory intent is clear, preventing ambiguity in enforcement and compliance. Distinguishing between color and general cosmetics, for instance, allows for tailored contaminant limits based on product type and exposure risk.
Case against: No specific case against the definitions themselves, but their technical nature can make the bill's full implications less accessible to a non-expert reader.
Estimated impact: These definitions clarify the scope of the bans and limits, directly impacting how manufacturers must test and formulate products and how the FDA will enforce the law.